KIMBERLY MARTINS: Open Payments
NPI 1275262230 · MIAMI BEACH, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$5,721 in 224 payments from 43 companies in 2025. Trend: 2023 $4,397 · 2024 $5,317 · 2025 $5,721
Food & beverage: $5,281Consulting: $300Education: $116Speaker / faculty: $24
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 24 | $721 |
| AstraZeneca Pharmaceuticals LP | 22 | $625 |
| Novartis Pharmaceuticals Corporation | 25 | $513 |
| GlaxoSmithKline, LLC. | 5 | $359 |
| Merck Sharp & Dohme LLC | 15 | $313 |
| Daiichi Sankyo Inc. | 13 | $290 |
| PFIZER INC. | 13 | $225 |
| Eisai Inc. | 9 | $188 |
| Takeda Pharmaceuticals U.S.A., Inc. | 7 | $179 |
| ABBVIE INC. | 7 | $172 |
Products named: RYBREVANT, OJJAARA, ENHERTU, KEYTRUDA, KISQALI, Lenvima, PLUVICTO, CARVYKTI.
Industry payments across FL — which companies pay providers there.
